PTGX
PTGX
US74366E1029
Protagonist Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
9.3B EUR
7.93B EUR
6.77B EUR
5.47B EUR
Enterprise Value
8.28B EUR
7.52B EUR
6.59B EUR
5.35B EUR
Valuation Multiples
Trailing P/E
139.54x
95.62x
--
--
Forward P/E
-721.72x
--
--
--
Price to Sales
32.98x
28.11x
91.4x
308.88x
Price to Book
11.05x
9.42x
10.33x
8.89x
EV/Revenue
29.36x
26.66x
88.92x
302.2x
EV/EBITDA
138.27x
125.52x
--
--
Price to FCF (P/FCF)
96.73x
60.71x
--
--
EV/FCF
86.12x
57.56x
--
--
FCF Yield
1.03%
1.65%
-1.74%
-1.26%
ende